Modifications in FLAP's second cytosolic loop influence 5-LOX interaction, inhibitor binding, and leukotriene...

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Leukotrienes are key inflammatory mediators synthesized through the 5-lipoxygenase (5-LOX) pathway.
• Efficient leukotriene synthesis depends on the interaction between 5-LOX and 5-LOX-activating protein (FLAP) at the nuclear membrane.

Purpose of the Study:

• To investigate the role of specific amino acid residues in FLAP's inhibitor binding pocket and cytosolic loops.
• To assess the impact of these mutations on 5-LOX product formation, FLAP inhibitor MK886 efficacy, 5-LOX translocation, and 5-LOX/FLAP complex formation.

Main Methods:

• Site-directed mutagenesis of FLAP.
• Assays to measure leukotriene production.
• Evaluation of FLAP inhibitor MK886 potency.
• Analysis of 5-LOX translocation and 5-LOX/FLAP complex formation.

Main Results:

• Mutations in FLAP's second cytosolic loop, particularly at residue S108, significantly reduced the potency of the FLAP inhibitor MK886.
• These mutations also disrupted the formation of the 5-LOX/FLAP complex.
• The study identified the second cytosolic loop of FLAP as crucial for the 5-LOX/FLAP interaction.

Conclusions:

• The second cytosolic loop of FLAP plays a critical role in mediating the 5-LOX/FLAP interaction necessary for leukotriene formation.
• Targeting this specific region of FLAP could lead to the development of novel FLAP inhibitors with enhanced pharmacokinetic properties for treating inflammatory conditions.